Cargando…

Insidious danger for young adults: Metabolic (dysfunction)-associated fatty liver disease

Detalles Bibliográficos
Autores principales:	Kaya, Eda, Yilmaz, Yusuf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2022
Materias:	Editorial - MAFLD in young adults
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243761/ https://www.ncbi.nlm.nih.gov/pubmed/35783479 http://dx.doi.org/10.14744/hf.2022.2022.0002

Ejemplares similares

Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

Non-invasive assessment of metabolic dysfunction–associated fatty liver disease
por: Chandra Kumar, C. Vikneshwaran, et al.
Publicado: (2022)

The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study
por: Yilmaz, Yusuf, et al.
Publicado: (2021)

Update on genetics and epigenetics in metabolic associated fatty liver disease
por: Zhu, Xiaopeng, et al.
Publicado: (2022)

The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
por: Yilmaz, Yusuf, et al.
Publicado: (2023)

The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease
por: Kulkarni, Anand V., et al.
Publicado: (2023)

MAFLD: what 2 years of the redefinition of fatty liver disease has taught us
por: Grabherr, Felix, et al.
Publicado: (2022)

High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis
por: Ergenc, Ilkay, et al.
Publicado: (2021)

Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges
por: Hegarty, Robert, et al.
Publicado: (2023)

How adolescent health influences education and employment: investigating longitudinal associations and mechanisms
por: Hale, Daniel R, et al.
Publicado: (2018)

The pathobiology of select adolescent young adult lymphomas
por: Steidl, Christian, et al.
Publicado: (2023)

Mature B‐cell lymphomas in adolescents and young adults
por: El‐Mallawany, Nader Kim, et al.
Publicado: (2023)

Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
por: Kaya, Eda, et al.
Publicado: (2022)

MAFLD: a multisystem disease
por: Pipitone, Rosaria Maria, et al.
Publicado: (2023)

Scientific techniques in adolescent and young adult classic Hodgkin lymphoma
por: Maura, Francesco, et al.
Publicado: (2023)

Disparities in care and outcomes for adolescent and young adult lymphoma patients
por: Rosenthal, Allison, et al.
Publicado: (2023)

Lymphoma in adolescents and young adults: Navigating a path forward together
por: Evens, Andrew M., et al.
Publicado: (2023)

The relationship between polyphenols and miRNAs: A novel therapeutic strategy for metabolic associated fatty liver disease
por: Merve Bayram, Hatice, et al.
Publicado: (2021)

Quantitative Survey on Prevalence of Prescription Pain Medications and Stimulants Use in Young Adults
por: Prakash, Sreelekha, et al.
Publicado: (2023)

Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma
por: Toner, Keri, et al.
Publicado: (2023)

Emerging pharmacological treatment options for MAFLD
por: Rojas, Ángela, et al.
Publicado: (2022)

Non-pharmacological management options for MAFLD: a practical guide
por: Stefano, José Tadeu, et al.
Publicado: (2023)

Should we undertake surveillance for HCC in patients with MAFLD?
por: Norero, Blanca, et al.
Publicado: (2023)

Screening for MAFLD: who, when and how?
por: Pal, Shreya C., et al.
Publicado: (2023)

Critical gaps in understanding treatment outcomes in adolescents and young adults with lymphoma: A review of current data
por: Pophali, Priyanka A., et al.
Publicado: (2023)

Her Health, Common Dangers and Salvation
por: O'Donovan, W. J.
Publicado: (1918)

Race, environment, young people and mental health
por: Craig, Mya-Rose
Publicado: (2021)

Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: A cross-sectional study using FibroScan
por: Yesil, Ezgi Ersoy, et al.
Publicado: (2023)

Das neu gewählte Team der AG Young DOG
por: Schnichels, Sven
Publicado: (2023)

Ovarian cancer: a molecularly insidious disease
por: Mezzanzanica, Delia
Publicado: (2015)

How has the pandemic changed healthcare for children and young people in the UK?
por: Uday, Sashank
Publicado: (2022)

Primary eye health care: what do young children need?
por: Mafwiri, Milka, et al.
Publicado: (2021)

Assessment of liver function before major hepatectomy
por: Arntz, Pieter, et al.
Publicado: (2023)

Die Organisation einer wissenschaftlichen Sitzung am Beispiel des Young Researcher Vision Camps
por: Hadrian, Karina, et al.
Publicado: (2021)

Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2020)

The cardiothoracic surgery trainee experience during the coronavirus disease 2019 (COVID-19) pandemic: Global insights and opportunities for ongoing engagement
por: Olive, Jacqueline K., et al.
Publicado: (2021)

Association of liver dysfunction with outcomes after cardiac surgery—a meta-analysis
por: Kirov, Hristo, et al.
Publicado: (2022)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
por: Lee, Jung Il
Publicado: (2022)

The comparison of resting metabolic rate between biopsy-proven non-alcoholic steatohepatitis and non-alcoholic fatty liver patients
por: Kenger, Emre Batuhan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_037ulhb9qs2jap69c7hrnogbog